RT @doctorRBC: C-VIEW Study: Certolizumab reduced Anterior Uveitis flares in AxSpA âï¸82% â¬ï¸ in uveitis flare ev
Tweet Content
C-VIEW Study: Certolizumab reduced Anterior Uveitis flares in AxSpA
⭐️82% ⬇️ in uveitis flare event
⭐️reduction in axSpA disease activity
⭐️no new safety signals
POS0897 #EULAR2021 @RheumNow https://t.co/182iHfkSTY
Show on Archive Page
On
Display in Search Results
On
PDQ
Off